|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar
|
|
2
|
Cohen SM, Shirai T and Steineck G:
Epidemiology and etiology of premalignant and malignant urothelial
changes. Scand J Urol Nephrol Suppl. 105–115. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Steineck G, Wiholm BE and Gerhardsson de
Verdier M: Acetaminophen, some other drugs, some diseases and the
risk of transitional cell carcinoma. A population-based
case-control study. Acta Oncol. 34:741–748. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baena AV, Allam MF, Del Castillo AS, et
al: Urinary bladder cancer risk factors in men: a Spanish
case-control study. Eur J Cancer Prev. 15:498–503. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Leppert JT, Shvarts O, Kawaoka K,
Lieberman R, Belldegrun AS and Pantuck AJ: Prevention of bladder
cancer: a review. Eur Urol. 49:226–234. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Johns LE and Houlston RS: N-acetyl
transferase-2 and bladder cancer risk: a meta-analysis. Environ Mol
Mutagen. 36:221–227. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Johns LE and Houlston RS: Glutathione
S-transferase mu1 (GSTM1) status and bladder cancer risk: a
meta-analysis. Mutagenesis. 15:399–404. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Leung DW, Cachianes G, Kuang WJ, Goeddel
DV and Ferrara N: Vascular endothelial growth factor is a secreted
angiogenic mitogen. Science. 246:1306–1309. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Seto T, Higashiyama M, Funai H, et al:
Prognostic value of expression of vascular endothelial growth
factor and its flt-1 and KDR receptors in stage I non-small-cell
lung cancer. Lung Cancer. 53:91–96. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Watson CJ, Webb NJ, Bottomley MJ and
Brenchley PE: Identification of polymorphisms within the vascular
endothelial growth factor (VEGF) gene: correlation with variation
in VEGF protein production. Cytokine. 12:1232–1235. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bae SJ, Ahn DH, Hong SP, et al:
Gender-specific association between polymorphism of vascular
endothelial growth factor (VEGF 936C>T) gene and patients with
stomach cancer. Yonsei Med J. 49:783–791. 2008. View Article : Google Scholar
|
|
13
|
Kawai Y, Sakano S, Korenaga Y, Eguchi S
and Naito K: Associations of single nucleotide polymorphisms in the
vascular endothelial growth factor gene with the characteristics
and prognosis of renal cell carcinomas. Eur Urol. 52:1147–1155.
2007. View Article : Google Scholar
|
|
14
|
Zhou Y, Li N, Zhuang W and Wu X: Vascular
endothelial growth factor (VEGF) gene polymorphisms and gastric
cancer risk in a Chinese Han population. Mol Carcinog. 50:184–188.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Garcia-Closas M, Malats N, Real FX, et al:
Large-scale evaluation of candidate genes identifies associations
between VEGF polymorphisms and bladder cancer risk. PLoS Genet.
3:e292007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brennan P, Bogillot O, Cordier S, et al:
Cigarette smoking and bladder cancer in men: a pooled analysis of
11 case-control studies. Int J Cancer. 86:289–294. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Johansson SL and Cohen SM: Epidemiology
and etiology of bladder cancer. Semin Surg Oncol. 13:291–298. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zeegers MP, Kellen E, Buntinx F and van
den Brandt PA: The association between smoking, beverage
consumption, diet and bladder cancer: a systematic literature
review. World J Urol. 21:392–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dai QS, He HC, Cai C, et al: Multicenter
case-control study of the relationship between smoking and bladder
cancer in China. Zhonghua Yi Xue Za Zhi. 91:2407–2410. 2011.(In
Chinese).
|
|
20
|
Manolio TA, Brooks LD and Collins FS: A
HapMap harvest of insights into the genetics of common disease. J
Clin Invest. 118:1590–1605. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rahim NG, Harismendy O, Topol EJ and
Frazer KA: Genetic determinants of phenotypic diversity in humans.
Genome Biol. 9:2152008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kouidhi S, Rouissi K, Khedhiri S, Ouerhani
S, Cherif M and Benammar-Elgaaied A: MTHFR gene polymorphisms and
bladder cancer susceptibility: a meta-analysis including race,
smoking status and tumour stage. Asian Pac J Cancer Prev.
12:2227–2232. 2011.PubMed/NCBI
|
|
23
|
Jiang Z, Li C and Wang X: Glutathione
S-transferase M1 polymorphism and bladder cancer risk: a
meta-analysis involving 33 studies. Exp Biol Med (Maywood).
236:723–728. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li DB, Wei X, Jiang LH, Wang Y and Xu F:
Meta-analysis of epidemiological studies of association of P53
codon 72 polymorphism with bladder cancer. Genet Mol Res.
9:1599–1605. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang DK, Ren WH, Yao L, Wang WZ, Peng B
and Yu L: Meta-analysis of association between TP53 Arg72Pro
polymorphism and bladder cancer risk. Urology. 76:765.e1–765.e7.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kellen E, Hemelt M, Broberg K, et al:
Pooled analysis and meta-analysis of the glutathione S-transferase
P1 Ile105Val polymorphism and bladder cancer: a HuGE-GSEC review.
Am J Epidemiol. 165:1221–1230. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jacobs EJ, Feigelson HS, Bain EB, et al:
Polymorphisms in the vascular endothelial growth factor gene and
breast cancer in the Cancer Prevention Study II cohort. Breast
Cancer Res. 8:R222006. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rodrigues P, Furriol J, Tormo E, Ballester
S, Lluch A and Eroles P: The single-nucleotide polymorphisms +936
C/T VEGF and -710 C/T VEGFR1 are associated with breast cancer
protection in a Spanish population. Breast Cancer Res Treat.
133:769–778. 2012.
|
|
29
|
Bruyere F, Hovens CM, Marson MN, et al:
VEGF polymorphisms are associated with an increasing risk of
developing renal cell carcinoma. J Urol. 184:1273–1278. 2010.
View Article : Google Scholar : PubMed/NCBI
|
